BCL2 and neoplasm: Therefore, if IGH-BCL2 translocation, MYD88 L265P mutation, and BRAF V600E mutation were also detected and the results were combined with the model, the overall predictive sensitivity could increase to 0.88, and was markedly improved in samples with low tumor cell content.